Cargando…

Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment

Mild cognitive impairment (MCI) is a prodrome of Alzheimer’s disease pathology. Cognitive impairment patients often have a delayed diagnosis because there are no early symptoms or conventional diagnostic methods. Exosomes play a vital role in cell-to-cell communications and can act as promising biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bo, Song, Li, Yang, Juan, Zhou, Wei-Ying, Cheng, Yuan-Yuan, Lai, Yu-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727429/ https://www.ncbi.nlm.nih.gov/pubmed/36018182 http://dx.doi.org/10.4103/1673-5374.347740

Ejemplares similares

Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres
por: Koba, Taro, et al.
Publicado: (2021)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Quantitative proteomic analysis of serum-purified exosomes identifies putative pre-eclampsia-associated biomarkers
por: Navajas, Rosana, et al.
Publicado: (2022)

The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis
por: Xing, Wenmin, et al.
Publicado: (2021)

Plasma exosome proteomics reveals the pathogenesis mechanism of post-stroke cognitive impairment
por: Qi, Baoyun, et al.
Publicado: (2023)

Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients
por: Yu, Haitao, et al.
Publicado: (2021)

Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
por: Rao, Dingyu, et al.
Publicado: (2023)

Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
por: Kovac, Viljem, et al.
Publicado: (2015)

Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases
por: Tsim, Selina, et al.
Publicado: (2021)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy
por: Yu, Zi-Wei, et al.
Publicado: (2020)

Fibulin-5 for youthful skin
por: Williams, Ruth
Publicado: (2007)

The Pathophysiological Significance of Fibulin-3
por: Livingstone, Imogen, et al.
Publicado: (2020)

Roles of Fibulin-2 in Carcinogenesis
por: Zhang, Huayue, et al.
Publicado: (2020)

Random-Forest-Algorithm-Based Applications of the Basic Characteristics and Serum and Imaging Biomarkers to Diagnose Mild Cognitive Impairment
por: Yang, Juan, et al.
Publicado: (2022)

Fibulin-4 and -5, but not Fibulin-2, are Associated with Tropoelastin Deposition in Elastin-Producing Cell Culture
por: Yamauchi, Yoshinori, et al.
Publicado: (2010)

Serum sTREM2: A Potential Biomarker for Mild Cognitive Impairment in Patients With Obstructive Sleep Apnea
por: Jiahuan, Xu, et al.
Publicado: (2022)

Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients
por: Grewal, Rinko, et al.
Publicado: (2016)

Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
por: Giau, Vo Van, et al.
Publicado: (2019)

Mismatch Negativity Latency as a Biomarker of Amnestic Mild Cognitive Impairment in Chinese Rural Elders
por: Ji, Li-Li, et al.
Publicado: (2015)

Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease
por: Maruff, Paul, et al.
Publicado: (2013)

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Identifying Alzheimer’s disease and mild cognitive impairment with atlas-based multi-modal metrics
por: Long, Zhuqing, et al.
Publicado: (2023)

A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer’s Disease by Peptidome Technology
por: Abe, Koji, et al.
Publicado: (2020)

Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Borkowski, Kamil, et al.
Publicado: (2021)

Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization
por: Woodard, DaNae R., et al.
Publicado: (2021)

Profile of Cognitive Complaints in Vascular Mild Cognitive Impairment and Mild Cognitive Impairment
por: Gu, Jenny, et al.
Publicado: (2013)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy
por: Ibrahim, Ayman M., et al.
Publicado: (2020)

Psychometric Evaluation of the Chinese Version of Mild Cognitive Impairment Questionnaire among Older Adults with Mild Cognitive Impairment
por: Dai, Qingmin, et al.
Publicado: (2022)

Estimating Bidirectional Transitions and Identifying Predictors of Mild Cognitive Impairment
por: Qin, Yao, et al.
Publicado: (2023)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Plasma microRNA biomarkers for detection of mild cognitive impairment
por: Sheinerman, Kira S., et al.
Publicado: (2012)

Characteristics of TCM Constitution and Related Biomarkers for Mild Cognitive Impairment
por: Deng, Xiangming, et al.
Publicado: (2021)

Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis
por: Hu, Congqi, et al.
Publicado: (2022)

Biomarker Extraction Based on Subspace Learning for the Prediction of Mild Cognitive Impairment Conversion
por: Li, Ying, et al.
Publicado: (2021)

Mutant Fibulin-3 Causes Proteoglycan Accumulation and Impaired Diffusion Across Bruch's Membrane
por: Zayas-Santiago, Astrid, et al.
Publicado: (2017)

Speech biomarkers of risk factors for vascular dementia in people with mild cognitive impairment
por: Martínez-Nicolás, Israel, et al.
Publicado: (2022)

Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review
por: Ding, Zihan, et al.
Publicado: (2022)

Identifying Amnestic Mild Cognitive Impairment With Convolutional Neural Network Adapted to the Spectral Entropy Heat Map of the Electroencephalogram
por: Li, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ep8hr16sjv1djd63poe382c5ja